EUCTR2015-001874-16-Outside-EU/EEA进行中（未招募）不适用
Placebo Controlled, Double Blind Evaluation of the Efficacy and Safety of Ibuprofen 5% Topical Gel for the Treatment of Ankle Sprain
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- Pfizer
- 入组人数
- 304
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- First or second degree ankle sprain within 48 hours of first dose of study medication
- •- Medically cleared to participate
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 150
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 54
排除标准
- •- Similar injury of same joint within last 6 months
- •- Requires bed rest, surgery, or over-the-counter or prescription analgesics
研究者
相似试验
已完成
3 期
Trial to Evaluate Role of a Probiotic- syrup on Antibiotic associated Diarrhoea in ChildreCTRI/2022/02/040138Synergia Lifesciences Pvt Ltd69
招募中
3 期
Does Dexmedetomidine[a sleep inducing drug] prevent injection pain due to Propofol [an anaesthetic drug]?- a studyCTRI/2012/01/002364S N Medical college100
进行中（未招募）
1 期
A clinical trial in patients with type II diabetes with increased risk of cardiovascular events (incidents that may cause damage to the heart muscle), to study how well a person’s diabetes is controlled over a 2-3 month period with bexagliflozin, by measuring blood sugar levels using a HbA1c test, and to determine safety by assessing occurrence of cardiovascular events.Type II diabetesMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2015-001760-19-NLTheracos Sub, LLC1,650
已完成
3 期
A double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse eventsType 2 diabetes and increased risk of cardiovascular adverse events100192801001842410003216NL-OMON47856Theracos Sub, LLC132
进行中（未招募）
1 期
A clinical trial in patients with type II diabetes with increased risk of cardiovascular events (incidents that may cause damage to the heart muscle), to study how well a person’s diabetes is controlled over a 2-3 month period with bexagliflozin, by measuring blood sugar levels using a HbA1c test, and to determine safety by assessing occurrence of cardiovascular events.Type II diabetesMedDRA version: 20.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861EUCTR2015-001760-19-DKTheracos Sub, LLC1,650